| Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 | Sep'10 | Sep'09 | Sep'08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
Net income | |||||||||||
80,237 | 85,407 | 88,877 | 80,553 | 72,591 | 65,891 | 55,959 | 11,479 | 9,340 | 11,338 | 14,395 | 54,490 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
ESOP and stock-based compensation expense | |||||||||||
11,780 | 11,356 | 11,252 | 13,436 | 13,980 | 12,157 | 11,356 | 11,115 | 10,138 | 13,141 | 13,169 | 11,790 |
Excess tax effect related to stock-based compensation | |||||||||||
- | - | - | - | - | - | - | - | 230 | 0 | 0 | - |
Depreciation and amortization | |||||||||||
22,950 | 25,187 | 20,885 | 19,369 | 17,453 | 13,285 | 21,315 | 22,767 | 19,404 | 18,465 | 18,504 | 8,846 |
Deferred income taxes | |||||||||||
21,936 | 3,949 | 3,548 | 11,099 | 9,185 | 9,659 | 6,486 | -19,270 | -8,243 | -10,542 | -15,510 | 1,106 |
Provision (credit) for loan losses | |||||||||||
-10,000 | -11,000 | -17,000 | -8,000 | -3,000 | 19,000 | 37,000 | 102,000 | 98,500 | 106,000 | 115,000 | 34,500 |
Net gain on the sale of loans | |||||||||||
1,869 | 3,383 | 2,183 | 6,161 | 4,519 | 2,031 | 8,267 | 688 | 490 | 25,303 | 32,850 | 3,896 |
Net gain on the sale of securities | |||||||||||
- | - | - | - | - | 276 | 0 | 0 | - | - | - | - |
Other net losses | |||||||||||
-116 | -1,127 | -562 | -613 | -2,962 | -2,529 | 756 | -2,027 | -3,419 | -2,316 | -15,786 | -12,245 |
Proceeds from sales of loans held for sale | |||||||||||
48,517 | 25,585 | 29,172 | 16,285 | 27,815 | 27,475 | 74,170 | 26,585 | 0 | 243,127 | 896,106 | 368,506 |
Loans originated for sale | |||||||||||
50,992 | 25,964 | 24,947 | 20,466 | 27,011 | 27,907 | 65,545 | 9,640 | 0 | 207,488 | 754,728 | 461,253 |
Increase in bank owned life insurance contracts | |||||||||||
6,192 | 6,138 | 6,320 | 4,854 | 6,491 | 6,449 | 6,468 | 6,480 | -6,519 | -6,489 | -6,588 | -6,659 |
Net (increase) decrease in interest receivable and other assets | |||||||||||
13,202 | 6,812 | 1,383 | 13,087 | 2,173 | 2,392 | -16,908 | -10,180 | -18,732 | 37,456 | -11,578 | -2,495 |
Net increase in accrued expenses and other liabilities | |||||||||||
-280 | -7,199 | -1,295 | -4,128 | 1,014 | -7,537 | -1,739 | 4,920 | -9,304 | 7,035 | -4,197 | 11,487 |
Other | |||||||||||
- | - | - | 255 | 296 | 104 | 391 | 631 | 821 | 2,380 | 1,352 | -4,654 |
Net cash provided by operating activities | |||||||||||
103,001 | 92,115 | 101,168 | 84,914 | 102,102 | 103,508 | 140,810 | 155,626 | 135,568 | 116,524 | 272,017 | 29,003 |
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||
Loans originated | |||||||||||
3,028,188 | 3,338,773 | 3,422,896 | 3,024,260 | 2,760,277 | 2,425,032 | 2,459,635 | 2,928,682 | 2,484,919 | 2,746,054 | 4,027,882 | 2,947,333 |
Principal repayments on loans | |||||||||||
2,629,397 | 2,508,822 | 2,494,866 | 2,310,358 | 2,052,276 | 1,783,108 | 2,369,786 | 2,185,787 | 1,787,544 | 1,886,218 | 2,550,830 | 1,377,465 |
Proceeds from principal repayments and maturities of: | |||||||||||
Securities available for sale | |||||||||||
152,560 | 139,846 | 153,315 | 154,520 | 153,945 | 157,389 | 206,388 | 74,589 | 10,898 | 8,857 | 8,948 | 27,964 |
Securities held to maturity | |||||||||||
- | - | - | - | - | - | - | 139,533 | 263,176 | 309,853 | 274,995 | 235,477 |
Proceeds from sale of: | |||||||||||
Loans | |||||||||||
69,620 | 372,497 | 218,158 | 186,705 | 133,456 | 48,564 | 282,221 | 0 | 33,722 | 792,511 | 1,339,799 | 373,634 |
Real estate owned | |||||||||||
3,997 | 6,280 | 8,761 | 22,400 | 25,134 | 25,738 | 25,817 | 22,731 | 15,606 | 17,421 | 12,880 | 10,708 |
Purchases of: | |||||||||||
FHLB stock | |||||||||||
8,314 | 3,554 | 20,137 | 383 | 29,059 | 4,791 | 0 | 0 | - | - | - | - |
Securities available for sale | |||||||||||
158,012 | 151,600 | 183,518 | 95,176 | 171,125 | 250,832 | 276,454 | 134,488 | 2,291 | 10,331 | 1,155 | 1,821 |
Securities held to maturity | |||||||||||
- | - | - | - | - | - | - | 93,509 | 12,424 | 380,072 | 35,602 | 229,456 |
Premises and equipment | |||||||||||
3,778 | 8,373 | 4,150 | 9,125 | 5,522 | 2,816 | 2,819 | 7,332 | 2,616 | 4,397 | 4,244 | 5,168 |
Death benefits on bank owned life insurance contracts | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | 673 |
Other | |||||||||||
-736 | 0 | -792 | -584 | -784 | -25 | 116 | -8 | 1,093 | -128 | -399 | -2,729 |
Net cash used in investing activities | |||||||||||
-341,982 | -474,855 | -754,809 | -454,377 | -600,388 | -668,647 | 145,188 | -741,363 | -392,397 | -125,866 | 118,968 | -1,155,128 |
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||
Net increase in deposits | |||||||||||
274,801 | 339,958 | -179,743 | 45,510 | -368,020 | 189,379 | -516,920 | 265,509 | -136,031 | 281,435 | 309,405 | 119,886 |
Net decrease in borrowers’ advances for insurance and taxes | |||||||||||
323 | 2,559 | 8,133 | 6,021 | 10,026 | 4,878 | 3,524 | 9,629 | -6,834 | -3,209 | 247 | -7,958 |
Net decrease in principal and interest owed on loans serviced | |||||||||||
1,419 | -4,276 | -13,635 | -92 | -5,177 | -21,075 | -51,794 | -24,320 | -132,566 | 178,706 | 25,044 | 2,767 |
Net increase(decrease) in short-term borrowed funds | |||||||||||
326,991 | 317,043 | 1,160,682 | 696,227 | 444,830 | -5,430 | -52,732 | 316,335 | 50,025 | 0 | -497,870 | 498,028 |
Proceeds from long-term borrowed funds | |||||||||||
275,000 | 15,088 | 0 | 40,290 | 600,294 | 450,000 | 320,000 | 35,000 | 34,673 | 0 | 70,000 | 0 |
Repayment of long-term borrowed funds | |||||||||||
420,709 | 281,809 | 208,100 | 186,349 | 15,136 | 51,048 | 10,342 | 3,000 | 15,000 | 0 | 0 | - |
Cash collateral received from (provided to) derivative counterparties | |||||||||||
-152,386 | 54,876 | 7,525 | 0 | 0 | - | - | - | - | - | - | - |
Purchase of treasury shares | |||||||||||
9,087 | 19,741 | 54,029 | 128,361 | 172,546 | 101,363 | 0 | 0 | - | 1,810 | 103,144 | 186,047 |
Excess tax benefit related to stock-based compensation | |||||||||||
- | - | - | 3,198 | 1,582 | 91 | 0 | 0 | 0 | 57 | 171 | 0 |
Acquisition of treasury shares through net settlement of stock benefit plans compensation | |||||||||||
1,538 | 1,772 | 2,504 | 7,697 | 4,111 | 0 | 0 | - | - | - | - | - |
Dividends paid to common shareholders | |||||||||||
50,465 | 37,629 | 27,709 | 23,414 | 19,490 | 4,886 | 0 | 0 | - | 15,561 | 19,677 | 13,803 |
Net cash provided by financing activities | |||||||||||
244,349 | 384,297 | 690,620 | 445,333 | 472,252 | 460,546 | -308,264 | 599,153 | -192,065 | 446,036 | -216,318 | 428,789 |
NET INCREASE IN CASH AND CASH EQUIVALENTS | |||||||||||
5,368 | 1,557 | 36,979 | 75,870 | -26,034 | -104,593 | -22,266 | 13,416 | -448,894 | 436,694 | 174,667 | -697,336 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |||||||||||
Cash paid for income taxes | |||||||||||
9,689 | 32,525 | 38,208 | 31,815 | 22,533 | 25,100 | 19,642 | 19,794 | 7,600 | 19,900 | 19,400 | 25,000 |
SUPPLEMENTAL SCHEDULES OF NONCASH INVESTING AND FINANCING ACTIVITIES: | |||||||||||
Transfer of loans to real estate owned | |||||||||||
3,473 | 4,238 | 7,989 | 12,134 | 23,761 | 27,000 | 27,741 | 23,006 | 21,069 | 17,310 | 32,412 | 26,729 |
Transfer of loans from held for investment to held for sale | |||||||||||
69,069 | 372,563 | 218,720 | 183,178 | 127,066 | 48,088 | 337,009 | 245,920 | 0 | 0 | - | - |
Transfer of Loans Held-for-sale to Portfolio Loans | |||||||||||
0 | 149 | 0 | 0 | - | - | 155,028 | 104,657 | 25,027 | 0 | 0 | - |
Treasury stock issued for stock benefit plans | |||||||||||
322 | 2,740 | 1,135 | 3,112 | 7,041 | 0 | 0 | - | - | - | - | - |
Transfer of investments from held to maturity to available for sale | |||||||||||
- | - | - | - | - | - | - | 343,687 | 0 | 0 | - | - |
Deposits | |||||||||||
Cash paid for interest | |||||||||||
143,363 | 100,505 | 87,373 | 89,947 | 93,093 | 92,143 | 111,707 | 153,463 | 178,452 | 210,810 | 255,163 | 328,133 |
Borrowed funds | |||||||||||
Cash paid for interest | |||||||||||
81,743 | 61,055 | 36,216 | 26,421 | 18,994 | 9,503 | 3,743 | 2,541 | 1,972 | 1,923 | 2,525 | 1,707 |